GLP-1 is a hormone produced in the intestines that works together with a receptor to control blood sugar
A compounded drugs active ingredients and their concentrations can vary significantly from an FDA-approved drug, which has raised some safety concerns
Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement
The matter was remanded back to FDA for reconsideration, and FDA issued a decision in December 2024 confirming the drug shortage was resolved
Alaska, Alabama, Arkansas, DC, Delaware, Kansas, Louisiana, Mississippi, North Dakota, New Mexico, Rhode Island, South Dakota, Vermont, West Virginia, and Wyoming are all excluded
Many long-term conditions, such as high blood pressure or diabetes, need ongoing treatment